The Food and Drug Administration has issued emergency use authorizations for two monoclonal antibody treatments for COVID-19 – one produced by Eli Lilly and another by Regeneron. But emergency use authorization doesn't assure the drugs are effective.In this episode of Short Wave, NPR's daily science podcast, science correspondent Richard Harris explains how the new treatments work — and whether they could really make a difference for patients with COVID-19. Listen to more episodes of Short Wave on Apple Podcasts or Spotify.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Nachrichten
Consider This from NPR Folgen
The hosts of NPR's All Things Considered help you make sense of a major news story and what it means for you, in 15 minutes. New episodes six days a week, Sunday through Friday.Support NPR and get your news sponsor-free with Consider This+. Learn more at plus.npr.org/considerthis
Folgen von Consider This from NPR
1588 Folgen
-
Folge vom 13.12.2020BONUS: How Effective Are Antibody Treatments For COVID-19?
-
Folge vom 11.12.2020White House Reporters Reflect On 4 Years As 'Enemies Of The People'President Trump once told veteran CBS journalist Lesley Stahl why he attacks the press. "I do it to discredit you all and demean you all," he admitted to her in 2017, "so when you write negative stories about me, no one will believe you."Trump made attacks on the press a central fixture of his campaign for president, and of his four years in the White House. As his term comes to a close, three members of the White House Press Corps reflect on what it's been like to cover the 45th president since the beginning. NPR's Tamara Keith, Jeff Mason of Reuters, and Yamiche Alcindor of the PBS NewsHour spoke to NPR's Mary Louise Kelly. In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 10.12.2020John Kerry: Restoring American Credibility On Climate Change 'Not So Simple'In his first round of interviews since President-elect Joe Biden announced John Kerry would be his special envoy for climate, the former Secretary of State tells NPR why restoring American credibility on climate issues will be a key challenge for the Biden administration. Kerry spoke to NPR's Steve Inskeep. NPR's Nathan Rott reports on another climate ambition for the incoming administration: conserving 30% of America's land and water by 2030. In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 09.12.2020Vaccine Approval Looks Imminent, But Distrust, Misinformation Have Experts WorriedThe Food and Drug Administration could vote as soon as Thursday to approve a COVID-19 vaccine developed by Pfizer for emergency use authorization in the United States. Speaking to NPR this week, FDA head Dr. Stephen Hahn reiterated the government's commitment to vaccine safety. But public opinion polls suggest many Americans are still skeptical of COVID-19 vaccines, and misinformation about them has been spreading online. Renee DiResta of the Stanford Internet Observatory tells NPR why misinformation often takes hold where people are not necessarily looking for it. NPR's Adrian Florido reports public health experts are worried that Latinos and African Americans — communities that are disproportionately affected by COVID-19 — may be less likely to get vaccinated. In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.Email us at considerthis@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy